|Application ||WB, E|
|Calculated MW||27513 Da|
|Antigen Region||1-30 aa|
|Other Names||Kallikrein-9, 3421-, Kallikrein-like protein 3, KLK-L3, KLK9|
|Target/Specificity||This Kallikrein 9 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1-30 amino acids from the N-terminal region of human Kallikrein 9.|
|Precautions||Kallikrein 9 Antibody (N-term) is for research use only and not for use in diagnostic or therapeutic procedures.|
|Tissue Location||Skin, thymus, trachea, cerebellum and spinal cord|
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. KLK9 is a novel kallikrein with poptential application for diagnosis, monitoring and therapeutics of various cancers including those of the breast, prostate and testis.
Yousef, G.M., et al., Genomics 65(2):184-194 (2000).
Diamandis, E.P., et al., Trends Endocrinol. Metab. 11(2):54-60 (2000).
Yousef, G.M., et al., Anticancer Res. 19 (4B), 2843-2852 (1999).
Yousef, G.M., et al., Anticancer Res. 79, 2843-2852 (1999).
If you have any additional inquiries please email technical services at email@example.com.